(Press-News.org) (Lebanon, NH, 5/24/13) — Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center will present a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with metastatic renal cell carcinoma (mRCC) at the ASCO Annual Meeting on June 3, 2013.
Metastatic renal cell carcinoma or kidney cancer is the seventh most common cancer, leading to approximately 116,000 deaths annually worldwide. In roughly one-quarter of those with mRCC, the cancer has already spread or metastasized at diagnosis.
Nivolumab is an immune checkpoint inhibitor being tested in many cancers such as advanced melanoma and nonsmall cell lung cancer. It helps the body fight renegade cancer cells by restoring normal T-cell antitumor function. T-cells are a type of white blood cell that act like soldiers by searching out and destroying invaders. Nivolumab accomplishes this by suppressing an immune checkpoint modulator.
In this study, Nivolumab will be used in combination with sunitinib, pazopanib (existing treatments), or ipilimumab. These existing treatments have shown to reduce progression of the disease, but without lasting or durable response. Many patients eventually develop resistance to them. In other Phase 1 and 2 clinical trials, Nivolumab has shown durable responses in patients with mRCC.
The ASCO poster session describes an ongoing four-arm Phase 1 dose-escalation and expansion study evaluating combinations of Nivolumab with sunitinib, pazopanib, or ipilimumab in patients with mRCC. The primary objectives are to assess safety and tolerability, and to determine the recommended Phase 2 dose in patients with mRCC. The secondary objective is to assess preliminary antitumor activity. Researchers will also evaluate overall survival, pharmacodynamics, predictive biomarkers for the combinations, pharmacokinetics and immunogenicity of Nivolumab.
###
Abstract No: TPS4593
Clinical Trial information: NCT01472081
About Norris Cotton Cancer Center at Dartmouth-Hitchcock
Norris Cotton Cancer Center combines advanced cancer research at Dartmouth College and the Geisel School of Medicine at Dartmouth College with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center, at Dartmouth-Hitchcock regional locations in Manchester, Nashua, and Keene, NH, and St. Johnsbury, VT, and at 12 partner hospitals throughout New Hampshire and Vermont. It is one of 41 centers nationwide to earn the National Cancer Institute's "Comprehensive Cancer Center" designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.
Dartmouth researchers test safety of Nivolumab in kidney cancer
2013-06-03
ELSE PRESS RELEASES FROM THIS DATE:
Cancer drug shortages hit 83 percent of US oncologists
2013-06-03
CHICAGO – Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510). The results showed that shortages – which have hit especially hard among drugs to treat pediatric, gastrointestinal and blood cancers – have ...
Patients with type 2 diabetes or hypertension must be evaluated for sleep apnea
2013-06-03
Baltimore - The American Academy of Sleep Medicine (AASM) is advising anyone with Type 2 diabetes or hypertension to be evaluated for sleep apnea by a board-certified sleep medicine physician. The recommendation comes as the group of international clinicians and researchers meets in Baltimore for SLEEP 2013, the foremost gathering of sleep experts annually.
Overwhelming clinical evidence has shown that patients suffering from two very common illnesses – Type 2 diabetes and hypertension – are at much higher risk for obstructive sleep apnea (OSA), a dangerous condition ...
Mutations in susceptibility genes common in younger African American women with breast cancer
2013-06-03
A high percentage of African-American women with breast cancer who were evaluated at a university cancer-risk clinic were found to carry inherited genetic mutations that increase their risk for breast cancer.
The finding suggests that inherited mutations may be more common than anticipated in this understudied group and may partially explain why African-Americans more often develop early onset and "triple-negative" breast cancer, an aggressive and difficult-to-treat form of the disease.
It also demonstrates the potential benefits of increased access to genetic counseling ...
Doctor's advice for cancer patients: Personal values influence treatment recommendations
2013-06-03
What treatment a doctor recommends for advanced cancer not only depends on medical aspects. His relationship to the individual patients and his own view of their life situation at their age play a role. This was found out by a research team led by Dr. Jan Schildmann of the Ruhr-Universität Bochum (RUB) together with colleagues from the University of Oxford. The RUB researchers also explored how patients perceive and evaluate the information they receive for clarification and decision making. The medical ethicists report in the journals "The Oncologist" and "Annals of Oncology".
One ...
Modern dragons in danger-- the relentless exploitation of Asian giant lizards revealed
2013-06-03
A new study reveals that Southeast Asian monitor lizards, representing the world's largest lizards, are harvested and traded for their skins and as pets in intangible volumes despite existing legislation – and much of this trade is illegal. Germany plays a major role in the international trade with live reptiles. On June 8th, 2013, the world's largest reptile fair will take place in Germany (Hamm, Westphalia).
A team of German and Indonesian scientists recently published a first comprehensive study on the conservation and threat status of all SE-Asian species of monitor ...
A healthy start
2013-06-03
The European Perinatal Health Report released by the EURO-PERISTAT project is the most comprehensive report on the health and care of pregnant women and babies in Europe and brings together data from 2010 from 26 European Union member states, plus Iceland, Norway and Switzerland. EURO-PERISTAT takes a new approach to health reporting. Rather than simply comparing countries on single indicators such as infant mortality, our report paints a fuller picture by presenting data about mortality, low birthweight and preterm birth alongside data about health care and maternal characteristics ...
New study predicts rising irrigation costs, reduced yields for US corn
2013-06-03
If the climate continues to evolve as predicted by the Intergovernmental Panel on Climate Change, the United States stands little to no chance of satisfying its current biofuel goals, according to a new study by Rice University and the University of California at Davis.
The study published online in the American Chemical Society journal Environmental Science and Technology suggests that in 40 years, a hotter planet would cut the yield of corn grown for ethanol in the U.S. by an average of 7 percent while increasing the amount of irrigation necessary by 9 percent.
That ...
Stem cell study could aid quest to combat range of diseases
2013-06-03
Scientists have taken a vital step forward in understanding how cells from skin tissue can be reprogrammed to become stem cells.
New research could pave the way to generate these stem cells efficiently to better understand and develop treatments for diseases such as multiple sclerosis, Parkinson's disease and muscular degeneration.
The study of how these cells – known as induced pluripotent stem cells (iPSCs) – were reprogramed was led by the University of Edinburgh and is published in the journal Nature.
Scientists found that the process by which iPSCs are created ...
An altered gut microbiota can predict diabetes
2013-06-03
Intestinal bacteria may have a greater influence on us than was previously thought. In a study published in the prestigious journal Nature on 29 May, researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden and Chalmers University of Technology, Sweden, show that patients with type 2 diabetes have an altered gut microbiota. Their findings have led to a new model to identify patients at increased risk of developing diabetes.
The human body contains ten times more bacteria than human cells. Most of these bacteria comprise the normal gut microbiota. Our bodies ...
Female moths use olfactory signals to choose the best egg-laying sites
2013-06-03
This news release is available in German.
Researchers at the Max Planck Institute for Chemical Ecology, Jena, Germany, discovered that the ability of Manduca sexta moths to recognize changes in the profile of volatile compounds released by plants being attacked by Manduca caterpillars allows them to lay their eggs on plants that are less likely to be attacked by insects and other predators, and to avoid competing against other caterpillars of the same species for resources. The results of field experiments and neurobiological studies were now published in the open ...